0 items

in your cart

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  • Click-to-Call  

Prescription Drug Search

Product Request Form

Ofatumumab is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.


*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about SaveRxCanada.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Ofatumumab:

  • Albania
  • Algeria
  • Antigua and Barbuda
  • Australia
  • Bahrain
  • Bangladesh
  • Bulgaria
  • China
  • Dominican Republic
  • Ecuador
  • Finland
  • Greece
  • Grenada
  • Guatemala
  • Hong Kong
  • India
  • Indonesia
  • Iran
  • Italy
  • Korea, South
  • Luxembourg
  • Mauritius
  • Moldova, Republic of
  • Monaco
  • New Zealand
  • Nicaragua
  • Norway
  • Panama
  • Paraguay
  • Peru
  • Philippines
  • Seychelles
  • South Africa
  • Sri Lanka
  • Switzerland
  • Turkey
  • United Kingdom, UK
  • United States, US
  • Vietnam
  • Yemen
View All Countries

Latest news releases on Ofatumumab:

Ofatumumab - Genmab - Home

Ofatumumab is a human monoclonal antibody which targets an epitope in the CD20 molecule encompassing parts of the small and large extracellular loops.

European Medicines Agency - Find medicine - Arzerra

Product details for Arzerra; Name: Arzerra: Agency product number: EMEA/H/C/001131: Active substance: ofatumumab. International non-proprietary name (INN) or common name

Product pipeline | GSK

Our medicines and vaccines in development are classified into three stages: phase I, phase II and phase III. These studies into the safety and efficacy of ...

Arzerra (ofatumumab) dosing, indications, interactions ...

Medscape - CLL dosing for Arzerra (ofatumumab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and ...

ARZERRA® (ofatumumab) | Patient Information

Discover ARZERRA® (ofatumumab), approved for 4 CLL treatment indications. Find dosing information & patient resources. See Important Safety Information & BOXED WARNING.

Ibrutinib versus Ofatumumab in Previously Treated Chronic ...

Original Article. Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia. John C. Byrd, M.D., Jennifer R. Brown, M.D., Ph.D., Susan O'Brien, M.D ...

FDA Drug Safety Communication: Boxed Warning and new ...

FDA Drug Safety Communication: Boxed Warning and new recommendations to decrease risk of hepatitis B reactivation with the immune-suppressing and anti-cancer drugs ...

Ofatumumab for Rituximab-Resistant Nephrotic Syndrome — NEJM

Correspondence. Ofatumumab for Rituximab-Resistant Nephrotic Syndrome. N Engl J Med 2014; 370:1268-1270 March 27, 2014 DOI: 10.1056/NEJMc1308488

Arzerra 100mg & 1000mg concentrate for solution for infusion

Arzerra 100mg & 1000mg concentrate for solution for infusion - Summary of Product Characteristics (SPC) by Novartis Pharmaceuticals UK Ltd

Rituxan (Rituximab) for RA, NHL, CLL, GPA and MPA

INDICATIONS. RITUXAN ® (rituximab) is indicated for the treatment of: Low-grade or follicular CD20-positive non-Hodgkin's lymphoma as a single-agent therapy in ...

Customer Service
1-866-799-3435 | Contact Form
Copyright © 2017 SaveRxCanada.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK